RISPERIDONE LONG-ACTING INJECTION (Risperdal Consta®)

Clinical Indication

Schizophrenia and other psychoses in patients tolerant to oral risperidone.

Comments

See the LLR Antipsychotic Prescribing Guide

Date of classification

September 2022

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .